Xinzhi Wei1,2, Xue Li1, Jie Du3, Xin Ge1,3, Yue Sun1, Xin Li1, Zhe Xun1, Weicheng Liu3, Zhan-You Wang4, Yan Chun Li3. 1. Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. 2. Experimental Center of Chinese Medicine, The First Affiliated Hospital, Liaoning University of Translational Chinese Medicine, Shenyang, Liaoning, China. 3. Division of Biological Sciences, Department of Medicine, The University of Chicago, 900 E. 57th Street, KCBD 9110, Chicago, IL, 60637, USA. 4. Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. wangzy@cmu.edu.cn.
Abstract
BACKGROUND: The renin-angiotensin system (RAS) is activated in inflammatory bowel disease (IBD), and vitamin D deficiency aggravates the development of colitis, but the relationship between the local colonic RAS and vitamin D is unclear with regard to the pathogenesis of IBD. AIMS: To investigate whether vitamin D suppresses the local colonic RAS to prevent colonic mucosal inflammation in a mouse model of experimental colitis. METHODS: C57BL/6 mice fed vitamin D-deficient (VDD) diet for 8 weeks were induced to colitis by 2,4,6-trinitrobenzenesulfonic acid (TNBS), with mice fed vitamin D-sufficient (VDS) diet as controls. Colitis severity was assessed by histology, and pro-inflammatory cytokines, RAS components, and signaling pathways were quantified by real-time RT-PCR and Western blotting. RESULTS: C57BL/6 mice fed the VDD diet for 8 weeks exhibited significantly lower serum 25(OH)D3 concentrations compared to mice fed the VDS diet. When these VDD mice were induced to colitis by TNBS, they exhibited more severe colonic inflammation and developed more severe colitis compared to the VDS counterparts. VDD diet feeding resulted in higher production of mucosal pro-inflammatory cytokines, higher activation of the myosin light chain kinase-tight junction regulatory pathway, and greater increases in mucosal permeability. VDD diet feeding also enhanced colonic RAS activation. Treatment with angiotensin II receptor blocker losartan markedly alleviated colitis in TNBS-induced VDD mice. CONCLUSION: Vitamin D deficiency promotes colonic inflammation at least in part due to over activation of the local RAS in the colon.
BACKGROUND: The renin-angiotensin system (RAS) is activated in inflammatory bowel disease (IBD), and vitamin D deficiency aggravates the development of colitis, but the relationship between the local colonic RAS and vitamin D is unclear with regard to the pathogenesis of IBD. AIMS: To investigate whether vitamin D suppresses the local colonic RAS to prevent colonic mucosal inflammation in a mouse model of experimental colitis. METHODS: C57BL/6 mice fed vitamin D-deficient (VDD) diet for 8 weeks were induced to colitis by 2,4,6-trinitrobenzenesulfonic acid (TNBS), with mice fed vitamin D-sufficient (VDS) diet as controls. Colitis severity was assessed by histology, and pro-inflammatory cytokines, RAS components, and signaling pathways were quantified by real-time RT-PCR and Western blotting. RESULTS: C57BL/6 mice fed the VDD diet for 8 weeks exhibited significantly lower serum 25(OH)D3 concentrations compared to mice fed the VDS diet. When these VDDmice were induced to colitis by TNBS, they exhibited more severe colonic inflammation and developed more severe colitis compared to the VDS counterparts. VDD diet feeding resulted in higher production of mucosal pro-inflammatory cytokines, higher activation of the myosin light chain kinase-tight junction regulatory pathway, and greater increases in mucosal permeability. VDD diet feeding also enhanced colonic RAS activation. Treatment with angiotensin II receptor blocker losartan markedly alleviated colitis in TNBS-induced VDDmice. CONCLUSION:Vitamin Ddeficiency promotes colonic inflammation at least in part due to over activation of the local RAS in the colon.
Authors: Ashwin N Ananthakrishnan; Hamed Khalili; Leslie M Higuchi; Ying Bao; Joshua R Korzenik; Edward L Giovannucci; James M Richter; Charles S Fuchs; Andrew T Chan Journal: Gastroenterology Date: 2011-12-09 Impact factor: 22.682
Authors: Lei He; Jie Du; Yinyin Chen; Chunyan Liu; Min Zhou; Sarbani Adhikari; David T Rubin; Joel Pekow; Yan Chun Li Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-04-17 Impact factor: 4.052
Authors: K Katada; N Yoshida; T Suzuki; T Okuda; K Mizushima; T Takagi; H Ichikawa; Y Naito; G Cepinskas; T Yoshikawa Journal: Inflamm Res Date: 2008-02 Impact factor: 4.575
Authors: Katherine Meckel; Yan Chun Li; John Lim; Masha Kocherginsky; Chris Weber; Anas Almoghrabi; Xindi Chen; Austin Kaboff; Farhana Sadiq; Stephen B Hanauer; Russell D Cohen; John Kwon; David T Rubin; Ira Hanan; Atsushi Sakuraba; Eugene Yen; Marc Bissonnette; Joel Pekow Journal: Am J Clin Nutr Date: 2016-06-08 Impact factor: 7.045
Authors: Ariel U Spencer; Hua Yang; Emir Q Haxhija; Barbara E Wildhaber; Joel K Greenson; Daniel H Teitelbaum Journal: Dig Dis Sci Date: 2007-03-07 Impact factor: 3.199
Authors: Maggie Ham; Maria S Longhi; Conor Lahiff; Adam Cheifetz; Simon Robson; Alan C Moss Journal: Inflamm Bowel Dis Date: 2014-05 Impact factor: 5.325
Authors: Yongyan Shi; Tianjing Liu; Lei He; Urszula Dougherty; Li Chen; Sarbani Adhikari; Lindsay Alpert; Guolin Zhou; Weicheng Liu; Jiaolong Wang; Dilip K Deb; John Hart; Shu Q Liu; John Kwon; Joel Pekow; David T Rubin; Qun Zhao; Marc Bissonnette; Yan Chun Li Journal: Sci Rep Date: 2016-06-08 Impact factor: 4.379
Authors: Jane Fletcher; Emma L Bishop; Stephanie R Harrison; Amelia Swift; Sheldon C Cooper; Sarah K Dimeloe; Karim Raza; Martin Hewison Journal: Endocr Connect Date: 2022-03-31 Impact factor: 3.221
Authors: Katherine M DiGuilio; Elizabeth Rybakovsky; Reza Abdavies; Romy Chamoun; Colleen A Flounders; Ariel Shepley-McTaggart; Ronald N Harty; James M Mullin Journal: Int J Mol Sci Date: 2022-03-10 Impact factor: 5.923